Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

1. Extensive Research Output

   • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos One, Oxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

   • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

2. Academic and Professional Leadership

   • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

   • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

3. Conference Participation and Recognition

   • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

   • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

4. Innovation and Patents

   • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

   • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

• M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

• Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

• President: Ideh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

• Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

• Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

• Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., Hypericin, Naringenin).

• Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506, Atorvastatin).

• Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

• Top National Medical Student (2021)

• Distinctive Researcher (2016–2020, Islamic Azad University)

• Best Startup Idea (2019, ITEM Weekend)

• Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

• Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
  Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
  Year: 2022
  Citations: 115

• Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
  Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
  Year: 2018
  Citations: 60

• Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
  Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
  Year: 2020
  Citations: 44

• Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
  Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
  Year: 2021
  Citations: 30

• Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
  Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
  Year: 2022
  Citations: 21

• Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
  Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
  Year: 2020
  Citations: 15

• Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
  Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
  Year: 2017
  Citations: 15

• Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
  Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
  Year: 2020
  Citations: 12

• Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
  Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
  Year: 2020
  Citations: 9

• Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
  Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
  Year: 2021
  Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.